Concordance between PD-L1 assays for metastatic renal cell carcinoma (mRCC) and metastatic urothelial carcinoma (mUC).
Year: 2019
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Duke University, Duke Medical Center, Duke Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4236493979
